Educational Directory
An educational index offering general summaries of common cancer types. This content is for awareness only and does not replace consultation with specialist medical professionals.
One of the most common cancers in women. Treatment depends on tumor subtype and molecular markers such as hormone receptors and HER2.
Divided into small-cell and non-small-cell types. Molecular profiling plays a central role in guiding targeted therapy.
A cancer of the colon or rectum. Molecular tests, including KRAS status and microsatellite markers, help select suitable therapies.
A skin cancer arising from pigment cells. Mutations such as BRAF link to targeted and immune-checkpoint options.
A cancer arising from stomach tissue. HER2 testing and other markers guide targeted-therapy decisions in a proportion of patients.
Usually starts in the cells covering the ovary. Genetic testing and maintenance therapy linked to BRCA genes play a role in management.
A common cancer in men. Its growth is usually tracked with PSA, and certain genetic changes are relevant to hormonal and targeted therapies.
A cancer of the cells lining the kidney tubules. Modern therapy includes vascular endothelial growth factor inhibitors and immune-checkpoint inhibitors.
The content on this website is for educational and informational purposes only. It is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider with any questions regarding a medical condition.
